PerspectiveThe Promise of America, Paid ForwardReflections on America's 250th — from a young student in a segregated D.C. classroom to Vice Chairman of the Federal Reserve, and the case for a more inclusive capitalism.Read Ideas & Happenings
Spotlights, perspectives, news, and field notes from across the Pamir portfolio.
PerspectiveThe Promise of America, Paid ForwardReflections on America's 250th — from a young student in a segregated D.C. classroom to Vice Chairman of the Federal Reserve, and the case for a more inclusive capitalism.Read 
PerspectiveAgentic AI and the Fax MachineWhy agentic AI's biggest near-term wins may be the unglamorous, high-stakes workflows — starting with the fax machines still running healthcare.Read 
NewsFront-Loading Drug Development: Q&A with Revalia Bio's Jenna DiRitoIn Applied Clinical Trials, Revalia Bio COO Jenna DiRito discusses how earlier, human-relevant data is reshaping go/no-go decisions in drug development.Read 
PerspectiveAt ARK Invest's Big Ideas SummitPamir's Anand Subramanian on a week in St. Petersburg with ARK Invest — an investor panel, a dinner of founders and policymakers, and the ideas moving markets.Read 
SpotlightAstrocade — $56M Series A & B Led by SequoiaTwo brothers spent four years building an AI gaming platform that ramped from zero to 140M game plays per month.Read 
NewsCondor Launches Advanced Analytics & Dynamic Scenario SuiteCondor's platform now spans the full R&D financial lifecycle, adding forecasting and dynamic scenario planning for life-sciences finance teams.Read 
SpotlightGreenCat — AI-Driven Catalyst DiscoveryGreenCat is transforming chemical discovery by pairing AI with autonomous labs to accelerate catalyst development.Read 
SpotlightCondor Software — $24M Series A Led by Insight PartnersThe first financial intelligence platform for life sciences, unifying clinical, operational, and financial data.Read 
PerspectiveReflecting on the 2026 Founders SummitPamir co-hosted the Founders Summit in Palm Beach — with Ken Langone, Bob Langer, and a community of technical founders.Read 
SpotlightRevalia Bio — Up to $26.7M ARPA-H ContractRevalia Bio is reimagining preclinical drug development by testing therapies on human organs, backed by one of the largest government contracts in startup history.Read 
PerspectiveThe Geopolitical Tipping PointA thesis on bio-industrial dominance through 2050 — why the nations that treat biotechnology as a sovereign industrial system, not a series of breakthroughs, will define the next half-century.Read 
NewsRevalia Bio — ARPA-H Award with Draper to Advance Human-Data TestingDraper and partners — including Revalia Bio, the Krishnaswamy Lab at Yale, and LifeShare Network — were awarded ARPA-H funding to develop new in-vitro testing methods for drug development.Read 
NewsRevalia Bio's Quest to Replace Animal Models with Human OrgansInside Precision Medicine profiles the platform testing drugs on donated human organs.Read 
PerspectiveScientist to founderA conversation on the journey from theoretical science to industry, with the co-founder and Chief Scientist of GreenCat.Read 
PerspectiveJPM Healthcare Breakfast 2026At JPM 2026, Pamir partners hosted a private breakfast with Norton Rose Fulbright, convening healthcare founders and investors around clinical proof and biology-native AI.Read 
PerspectiveRoger Ferguson at the Milken Institute Global ConferencePamir co-founder Roger Ferguson — former Fed Vice Chair and TIAA CEO — on the economy, markets, and reading inflection points before they arrive.Read